product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-Mcl-1 (Ser159/Thr163) Antibody
catalog :
4579
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
antigen modification :
phosphorylated
reactivity :
human, mouse
application :
western blot, immunoprecipitation
citations: 1
Published Application/Species/Sample/DilutionReference
  • western blot; human; 1:1000; fig st1
Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
product information
SKU :
4579S
Product-Name :
Phospho-Mcl-1 (Ser159/Thr163) Antibody
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H
Applications :
Immunoprecipitation
Product-Category :
Apoptosis
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
42
Host :
Rabbit
Target :
MCL1 (Ser159/Thr163) phosphate
Primary-Protein :
MCL1
Alt-Names :
BCL2L3,Bcl-2-like protein 3,Bcl-2-related protein EAT/mcl1,Bcl2-L-3,EAT,Induced myeloid leukemia cell differentiation protein Mcl-1,MCL1,MCL1L,MCL1S,MGC104264,MGC1839,Mcl-1,TM,mcl1/EAT,myeloid cell leukemia ES,myeloid cell leukemia sequence 1 (BCL2-related),myeloid cell leukemia sequence 1, isoform 1
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.